Grimes & Company’s Zoetis ZTS Stock Holding History

Grimes & Company’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,379	Closed	-$202K	–	486
2025 Q3	$202K	Sell	1,379 -30	-2%	-$4.54K	0.01%	439
2025 Q2	$220K	Buy	1,409 +23	+2%	+$3.65K	0.01%	393
2025 Q1	$228K	Buy	1,386 +98	+8%	+$16.3K	0.01%	333
2024 Q4	$210K	Sell	1,288 -59	-4%	-$10.6K	0.01%	362
2024 Q3	$263K	Buy	+1,347	New	+$248K	0.01%	315

Other funds holding ZTS

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Grimes & Company's ZTS Position: Q4 2025 in Review

Grimes & Company sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 1,379 shares — an estimated $202K sold.

Grimes & Company first reported a position in ZTS in Q3 2024 and held it in 5 quarters. The position peaked at $263K in Q3 2024. 1,680 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

Grimes & Company reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
Grimes & Company sold 1,379 Zoetis shares in Q4 2025, an estimated $202K.
Grimes & Company first reported a position in Zoetis in Q3 2024 and held it in 5 quarters.
Grimes & Company's Zoetis position peaked at $263K in Q3 2024.
1,680 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Grimes & Company's 13F filing for Q4 2025, filed 3 Feb 2026.